This inventor holds 1 USPTO granted patent. Top assignee: Pharma-Zentrale Gmbh. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Ulrich Zähringer: Innovator in Lipopolysaccharide Research
Introduction
Ulrich Zähringer is a notable inventor based in Garbsen, Germany. He has made significant contributions to the field of biochemistry, particularly in the extraction and processing of lipopolysaccharides from Escherichia coli. His work has implications for various applications in medicine and biotechnology.
Latest Patents
Zähringer holds a patent for lipopolysaccharides (LPS) extracted from Escherichia coli. The patent details processes for producing these lipopolysaccharides, which consist of a lipid A portion, a core oligosaccharide portion, and an O-specific chain featuring a single repeating unit 06. The production method involves washing and drying bacterial mass, followed by phenol/water extraction and treatment with RNases, DNases, and proteinase K.
Career Highlights
Ulrich Zähringer is associated with Pharma-Zentrale GmbH, where he continues to advance research in his field. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Zähringer has worked alongside notable colleagues such as Hans Proppert and Jürgen Malinka. Their collaborative efforts have contributed to the advancement of research in lipopolysaccharides and related areas.
Conclusion
Ulrich Zähringer's work in lipopolysaccharide research exemplifies the impact of innovative thinking in biochemistry. His contributions continue to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile